June 10, 2022 - New Trial for Pediatric Brain Cancer - and more news

June 10, 2022 IN THIS ISSUE Top News | Foundation News | Symposium News | Patient News Research News | Industry News | Events     New Trial of Focused Ultrasound for Pediatric Brain Cancer Researchers at Children’s National Hospital have begun a clinical trial to address deadly pediatric brain tumors called diffuse intrinsic pontine gliomas (DIPG). The trial will use focused ultrasound—induced sonodynamic therapy to kill tumor cells. Another clinical trial for DIPG using focused ultrasound to disrupt the blood-brain barrier is being planned for later this year at Children's National. READ MORE > Foundation News Foundation Event Raises Awareness of Focused Ultrasound for Brain Disorders The Foundation hosted a local awareness event for supporters and friends in the community. Presentations covered current research for brain tumors, psychiatric conditions, Parkinson’s disease, and Alzheimer’s disease. READ MORE > Symposium News Thank you to the more than 300 clinicians and researchers who submitted abstracts for the Symposium. Presentation notifications will be sent in early August. Preliminary Symposium Program Now Available  The program outlines daily topics to be addressed; however, the schedule will be weighted according to the number of abstracts for each category. A final program will be available later this summer. SEE THE PROGRAM >  Interested in receiving the latest Symposium news? Subscribe now! Patient News Patient Shares Her Experience in Focused Ultrasound Trial for Liver Tumors When Heather’s cancer spread to her liver, she participated in the #HOPE4LIVER focused ultrasound clinical trial. She was treated last October by an all-female team in Wisconsin, and her tumors haven’t recurred. The trial, which uses histotripsy to mechanically destroy target tissue, recently completed enrollment. WATCH THE VIDEO >  More Patient News How HIFU Helps in Fibroid Treatment — Expert Daily Trust (Nigeria) Henry Ford Health First in Michigan to Treat Prostate Cancer with Robotic HIFU | DOTmed Healthcare Business News Research News Clinical Trial of Focused Ultrasound for Cervical Dystonia Begins The first patient has been treated in a clinical trial in Tokyo that is using focused ultrasound to address cervical dystonia. Cervical dystonia is a painful condition in which neck muscles contract uncontrollably. The Foundation is funding this 10-patient trial. READ MORE >  First Patient Treated in Focused Ultrasound Trial to Enhance Radiotherapy A new clinical trial in Taiwan is using the NaviFUS® focused ultrasound system in combination with radiotherapy in patients with primary brain tumors. Preclinical studies suggest that opening the blood-brain barrier to enhance oxygenation of brain tissue could make radiotherapy more effective. The Foundation is funding this eight-patient trial. LEARN MORE ABOUT THE TRIAL >  New Cancer Immunotherapy Platform Harnesses Power of Therapeutic Ultrasound Researchers at MD Anderson have developed and tested a new therapeutic ultrasound treatment platform that improves two types of cancer immunotherapy. The system is called “MUSIC,” or Microbubble-assisted, UltraSound-guided Immunotherapy of Cancer. MUSIC can be used to image and burst microbubbles that have accumulated on tumors. READ MORE >  Meeting Report: 2022 American Urological Association (AUA) Annual Meeting The 2022 AUA Annual Meeting was held in New Orleans from May 13–16. Two educational offerings and 13 abstracts involved high-intensity focused ultrasound (HIFU). Three of the HIFU manufacturers in the prostate space participated in the meeting. READ MORE >  Columbia University Fellow Receives Award for Focused Ultrasound Research Matthew Gallitto, MD, a postdoctoral clinical fellow at Columbia University, has received an ASCO Young Investigator Award. He is researching focused ultrasound—induced blood-brain barrier disruption to address diffuse intrinsic pontine gliomas (DIPG). READ MORE >  Industry News HistoSonics’ #HOPE4LIVER Studies Complete Enrollment HistoSonics announced that parallel clinical trials in the US and Europe to evaluate histotripsy to destroy liver tumors have completed enrollment. Histotripsy involves using focused ultrasound to mechanically destroy and liquefy targeted tissue. The company plans to use the data to apply for US Food and Drug Administration approval. READ THE PRESS RELEASE >  HEAR FROM A TRIAL PARTICIPANT > The Complex Ecosystem of a Medical Device Startup In this blog, Mark Carol, MD, a senior consultant at the Foundation, shares his insight on piloting a medical device startup from conception to commercialization. This is the first in a series of blogs addressing the processes, trials, and tribulations involved in bringing a new medical technology to market. READ MORE >  More Industry News An Expert’s View on HIFU as an Innovation in Urology | Urology Times Barriers and Opportunities in Active Surveillance, HIFU, and Focal Therapy in Latin American Countries - Laurence Klotz | URO Today [video] GE Healthcare Signs Up to Distribute HistoSonics' Soundwave Therapy for Liver Cancer | Fierce Biotech | See additional coverage in Mass Device and MDDI Research Utilizing Sonablate HIFU Recognized in Award Winning Session During the 2022 AUA Annual Meeting | EIN News TULSA-PRO® was Front and Center at AUA2022 | Globe Newswire Do you have news for our newsletter? Tell us about it!   Upcoming Events June 11-16, 2022 Society of Interventional Radiology (SIR) Annual Meeting, Boston, MA June 19-23, 2022 15th International Stereotactic Radiosurgery Society (ISRS) Congress, Milan, Italy July 10-14, 2022 American Association of Physicists in Medicine (AAPM) Annual Meeting, Washington, DC August 14-19, 2022 Gordon Research Conference – In Vivo Ultrasound Imaging, Ventura, CA October 10-13, 2022 IEEE International Ultrasonics Symposium, Venice, Italy October 23-28, 2022 8th International Symposium on Focused Ultrasound, Bethesda, MD December 8-11, 2022 International Symposium on Biomolecular Ultrasound and Sonogenetics (ISBUS), Pasadena, CA